Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181740 · ClinicalTrials.gov registry record · Phase 4
Concerta Treatment in Adults With ADHD NOS
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00181740: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT00181740 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00181740, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
This will be an open label pilot study of Concerta in the treatment of adults with the diagnosis of Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS). We hypothesize ADHD symptomatology in adults with ADHD NOS will be responsive to Concerta treatment in the short term and Concerta-associated response of ADHD symptomatology in adults with ADHD NOS will be sustained over the medium term.
Interventions
- DRUG atomoxetine (Strattera)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-12 |
| Est. Completion | 2005-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00181740
The ClinicalTrials.gov registry entry for NCT00181740 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which atomoxetine (Strattera) is the first listed.
NCT00181740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00181740 about?
NCT00181740 is a clinical study titled "Concerta Treatment in Adults With ADHD NOS". This will be an open label pilot study of Concerta in the treatment of adults with the diagnosis of Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS). We hypothesize ADHD symptomatology in adults with ADHD NOS will be responsive to Concerta treatment in the short term and C...
What is the current status of trial NCT00181740?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2003-12. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00181740?
The interventions under investigation include: atomoxetine (Strattera) (DRUG).
Who is sponsoring clinical trial NCT00181740?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.